These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7676148)

  • 1. [Immunomodulator effects of intravenous immunoglobulins in neurological autoimmune diseases].
    Mouthon L; Kaveri SV; Kazatchkine MD
    Rev Neurol (Paris); 1995 Feb; 151(2):91-2. PubMed ID: 7676148
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD
    Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin and autoimmunity.
    Zandman-Goddard G
    Isr Med Assoc J; 2010 Jan; 12(1):45-6. PubMed ID: 20450130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of immunoglobulin in the therapy of neurological illnesses].
    Elovaara I; Färkkilä M; Hietaharju A; Pirttilä T
    Duodecim; 2001; 117(10):1033-41; quiz 1041, 1081. PubMed ID: 12116461
    [No Abstract]   [Full Text] [Related]  

  • 5. Basic principles of intravenous immunoglobulin (IVIg) treatment.
    Stangel M; Pul R
    J Neurol; 2006 Sep; 253 Suppl 5():V18-24. PubMed ID: 16998749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous immunoglobulins in dermatology].
    Nydegger U; Hunziker T
    Ann Dermatol Venereol; 2002; 129(8-9):1078-81. PubMed ID: 12442118
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined use of plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Rieben R
    Ann Med Interne (Paris); 1994; 145(5):287-92. PubMed ID: 7985933
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives].
    Wintzell A; Eriksson T; Lundgren A; Petersson J
    Lakartidningen; 2008 May 21-27; 105(21):1571-5. PubMed ID: 18574994
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
    Mouthon L; Hurez V; Kazatchkine M
    Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immune globulin in autoimmune and inflammatory diseases.
    Gelfand EW
    N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immunoglobulins in neurological diseases.
    Zettl UK; Mix E
    J Neurol; 2006 Sep; 253 Suppl 5():V1. PubMed ID: 16998748
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous immunogloblins: myth and reality.
    Tellier Z
    Isr Med Assoc J; 2005 Dec; 7(12):762-7. PubMed ID: 16382695
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive mechanisms for immunoglobulin function].
    Miller A; Jedrzejczak WW
    Postepy Hig Med Dosw; 2000; 54(4):423-44. PubMed ID: 11016265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.
    Dalakas MC
    Pharmacol Ther; 2006 Oct; 112(1):57-70. PubMed ID: 16644016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical approach to the use of intravenous immunoglobulin in neurological disease.
    Wills AJ; Unsworth DJ
    Eur Neurol; 1998; 39(1):3-8. PubMed ID: 9476717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Current Strategies for Drug Discovery Targeting Neurological Autoimmune Diseases.
    Skundric DS
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):3. PubMed ID: 29474167
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases].
    Lewańska M; Selmaj K
    Postepy Hig Med Dosw; 2002; 56 Suppl():69-83. PubMed ID: 12661417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.